Table 1 Patient characteristics
Sex | Patients (%) |
|---|---|
Female | 0 (0.0 %) |
Male | 45 (100 %) |
Age, median (year, range) | 65 (60–72) |
Primary tumor site | |
Bladder | 30 (66.7 %) |
Ureter or renal pelvic | 6 (13.3 %) |
Ureter or renal pelvic with bladder | 9 (20.0 %) |
Nodal status | |
N0 | 6 (13.3 %) |
N1 | 8 (17.8 %) |
N2 | 19 (42.2 %) |
N3 | 12 (26.7 %) |
Distant metastatic site at the time of MVAC administration | |
Lung | 21 (46.7 %) |
Bone | 16 (35.6 %) |
Liver | 9 (20.0 %) |
Other | 4 (8.9 %) |
Absence | 16 (35.6 %) |
Single | 13 (28.9 %) |
Multiple | 16 (35.6 %) |
ECOG performance status (PS) | |
PS 0 | 20 (44.4 %) |
PS 1 | 23 (51.1 %) |
PS 2 | 2 (4.4 %) |